PropertyValue
?:abstract
  • I apply concepts and tools from evolutionary medicine to understanding the SARS-COV-2 pandemic. The pandemic represents a mismatched conflict, with dynamics and pathology apparently driven by three main factors: (1) bat immune systems that rely on low inflammation but high efficacy of interferon-based defences; (2) viral tactics that differentially target the human interferon system, leading to substantial asymptomatic and presymptomatic transmission; and (3) high mortality caused by hyper-inflammatory and hyper-coagulatory phenotypes, that represent dysregulated tradeoffs whereby collateral immune-induced damage becomes systemic and severe. This framework can explain the association of mortality with age (which involves immune life-history shifts towards higher inflammation and coagulation, and reduced adaptive immunity), and sex (since males senesce faster than females). Genetic-risk factors for Covid-19 mortality can be shown, from a phenome-wide association analysis of the relevant SNPs, to be associated with inflammation and coagulation; the PheWAS also provides evidence, consistent with several previous studies, that the calcium channel blocking drug amlodipine mediates risk of mortality.
is ?:annotates of
?:creator
?:doi
  • 10.1093/emph/eoaa036
?:doi
?:journal
  • Evol_Med_Public_Health
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/3069a62f0865a367b80e02397e2312ab623738ba.json
?:pmcid
?:pmid
?:pmid
  • 33335737.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • Evolutionary medical insights into the SARS-CoV-2 pandemic
?:type
?:year
  • 2020-10-14

Metadata

Anon_0  
expand all